New Delhi, Delhi, India: APCER, a leading global Pharmacovigilance services company that brings together safety, medical, regulatory and technology resources to ensure that patients receive the safest, most effective therapies possible, has announced the appointment of Dr Taku Seriu – a globally respected scientist and business leader in the pharmaceutical industry – as […]
Vinay Maurya
RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs
San Carlos, Calif., United States: RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies with […]
Chronic Kidney Disease: The Reality by Dr. L H Hiranandani Hospital
Mumbai, Maharashtra, India: Chronic kidney disease is characterized by a gradual and cumulative loss of kidney function over many years. This disease frequently goes unnoticed and undiagnosed until the condition has progressed significantly. Generally, people don’t realize they have chronic kidney failure until their kidney function has dropped to […]
Merck Foundation and African First Ladies Mark ‘World Health Day’ 2021 by Providing Scholarships for Doctors in New Specialities in Africa and Asia
Windhoek, Namibia & Mumbai, Maharashtra, India: Merck Foundation, year to date, in partnership with African First Ladies and Ministers of Health, have provided for more than 1100 doctors from 42 Countries with 1 & 2 year speciality scholarship to improve access to quality and equitable healthcare in Africa, Asia, […]
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Copenhagen, Denmark & Ingelheim, Germany: New studies mark an important advancement of Boehringer Ingelheim’s cardiometabolic focus areas obesity and NASH. The GLP-1/glucagon dual agonist BI 456906 may offer important benefits on both chronic weight management and NASH improvement. The Phase 2 trials for BI 456906 in obesity and NASH […]
GLIDE Launches Inaugural Awards for Disease Elimination
Abu Dhabi, United Arab Emirates & London, United Kingdom: – New Abu Dhabi-based global health Institute launches its first disease elimination awards – 5 awards of up to USD200,000 each The Global Institute for Disease Elimination (GLIDE), a new Abu Dhabi-based global health Institute focused on eliminating infectious diseases […]
LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer
Guangzhou, China: LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that China’s health authority, National Medical Products Administration (NMPA) authorized the company to proceed with a Phase 1/2 clinical trial (clinicaltrials.gov: NCT04799847) evaluating […]
Games Industry Reflects on and Recommits to #PlayApartTogether Campaign at One Year Milestone
San Francisco, United States: Today, leaders from the global games industry who participated in #PlayApartTogether committed to reactivate the initiative launched one year ago, which encourages gamers everywhere to follow World Health Organization (WHO) health advice on COVID-19 prevention. This press release features multimedia. View the full release […]
Offender DNA Database Will Be Strong Deterrent to Repeat Crimes in India
New Delhi, Delhi, India: Building quality conviction and DNA profiling can effectively reduce repeat offense by more than 40% Increased severity of punishment not a strong deterrent of crime, reveal international studies As the country debates and scrutinizes the merits of instituting a national databank of crime scene DNA […]
Diaceutics Appoints Yvanka Gilliam as Vice President of Operations, Asia Pacific
Parsippany, N.J., United States: Yvanka Gilliam brings a wealth of industry experience to the company, having worked in pharma for more than 20 years Prior to Diaceutics, she had roles in Kantar Health, IQVIA Asia Pacific and AstraZeneca Yvanka will be responsible for managing business development and operations in […]